The top vaccine and biologics drug official in the U.S. Food and Drug Administration will step down in April. The agency made ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

GSK (GSK) stock is in focus as the U.S. FDA expands authorization for the company's Arexvy RSV vaccine to cover adults 18–49. Read more here.

COVID-19 cases remained relatively steady week-over-week in late August, though data from states showed "very high" viral activity at the end of the month, according to the Centers for Disease Control ...

Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its Covid 19 vaccines. The agreement includes a ...

BioNTech (NASDAQ:BNTX) management outlined a strategy centered on late-stage oncology execution and combination-based development during the company’s fourth-quarter and full-year 2025 earnings call, ...

If you're looking for the most hated stocks on Wall Street, start with this list. All seven companies are worth more than $1 billion but have more than 30% of their available shares held by short ...

Team USA is viewed as the favorite to win the WBC, which it last won in 2017. Japan is a three-time champion, winning most recently in 2023. Among McCarthy's options: Ride out 2026 and hope for ...